Side effects
Mounjaro side effects: what is normal and what is not
- Published
- 26 August 2026
- Updated
- 26 August 2026
- Clinically reviewed
- 26 August 2026
- Next review due
- 26 August 2027
The short answer
Most Mounjaro side effects are digestive, mild, and worst in the week after a dose increase. Nausea affects around 18% of people in trials, diarrhoea around 15% and constipation around 12%. Severe abdominal pain, persistent vomiting, or signs of dehydration are not normal and need same-day clinical advice.
Key takeaways
- 1Side effects are most likely in the seven days after a dose step-up.
- 2Nausea, diarrhoea and constipation are the three most common.
- 3Eating smaller portions and protein first reduces nausea for most people.
- 4A dose can be held or reduced — escalation is not compulsory.
- 5Severe, constant abdominal pain radiating to the back needs urgent review.
The pattern side effects follow
Almost all Mounjaro side effects follow the dose, not the calendar. The week after a step-up is when the gut is adjusting, and that is when nausea, loose stools or constipation are most likely. By the third or fourth week on a given dose, most people feel normal again — which is exactly why the ladder moves no faster than every four weeks.
Common, and expected
| Effect | Roughly how common | What helps |
|---|---|---|
| Nausea | About 18% | Smaller meals, protein first, avoid greasy food |
| Diarrhoea | About 15% | Fluids, plain food for a day or two |
| Constipation | About 12% | Water, fibre, movement |
| Reduced appetite | Very common | Expected — the medicine working |
| Injection-site reaction | Uncommon | Rotate the site each week |
Not normal — contact a clinician
- Severe abdominal pain, particularly if it is constant and spreads to your back.
- Vomiting that stops you keeping fluids down for more than a day.
- Signs of dehydration: very dark urine, dizziness on standing, no urine for eight hours.
- Yellowing of the eyes or skin, or pale stools.
- Sudden changes in vision, if you have diabetic retinopathy.
Reducing your chances
- 1Inject on a day when you have a quiet evening, not before a big meal out.
- 2Eat protein first at every meal, and stop when you are comfortable rather than full.
- 3Keep alcohol low in the week after a step-up.
- 4Drink more water than feels necessary.
- 5Tell your clinician early — a held dose is cheaper than a stopped course.
Speak to a clinician
This article is general information about UK-licensed medicines, not advice about your own treatment. If something you are experiencing worries you, or you are considering a change to your dose or medicine, speak to your prescriber before acting on anything you read here.
Questions people ask
How long do Mounjaro side effects last?
For most people, a few days after each dose increase. Nausea typically appears within 48 hours of the injection and settles within a week. If a side effect is still troubling you three weeks into a dose, speak to your clinician rather than stepping up.
Can I stay on a lower dose if it is working?
Yes. There is no obligation to reach the highest dose. If your appetite is controlled and your weight is moving at 5mg or 7.5mg, staying there is a legitimate clinical decision and is often the more sustainable one.
Does eating differently really reduce nausea?
It makes a measurable difference for most people. Smaller portions, protein before carbohydrate, and avoiding greasy or very sweet food in the two days after an injection are the changes patients report help most.
Should I stop if I get diarrhoea?
Not usually. Mild diarrhoea in the days after a dose increase is common and settles. Keep your fluids up. Stop and seek advice if you cannot keep fluids down, if it lasts beyond a few days, or if you feel light-headed.
Written by
ClariDay Editorial Team
Health writers
Our writers research and draft every article using the UK product licence, the published trial data and MHRA guidance. Nothing is published until a prescriber has checked it.
- Plain-English health writing
- Evidence summaries
Last updated 26 August 2026
Medically reviewed by
Mr Ali Salih
Independent Prescriber & Clinical Lead · GPhC 2212755
MPharm, Independent Prescriber
Ali is the clinical lead at ClariDay and a GPhC-registered independent prescriber. He reviews every treatment page and clinical article on this site for accuracy against the current UK product licences and prescribing guidance.
- Weight management
- GLP-1 and GIP therapies
- Prescribing safety
Reviewed 26 August 2026 · next review 26 August 2027
UK registered pharmacy and prescribers
Every clinical claim cited
Tracked, temperature-aware delivery
